KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,585.00
-170.00 (-6.17%)
At close: Apr 13, 2026

KMPHARMACEUTICAL Revenue

In the year 2025, KMPHARMACEUTICAL had annual revenue of 15.99B KRW with 10.47% growth. KMPHARMACEUTICAL had revenue of 4.29B in the quarter ending December 31, 2025, with 26.41% growth.

Revenue
15.99B
Revenue Growth
+10.47%
P/S Ratio
0.90
Revenue / Employee
275.69M
Employees
58
Market Cap
14.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.99B1.52B10.47%
Dec 31, 202414.47B-3.29B-18.54%
Dec 31, 202317.77B2.14B13.68%
Dec 31, 202215.63B-7.07B-31.15%
Dec 31, 202122.71B-223.00M-0.97%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Beauty Skin54.92B
HuM&C52.31B
Medience48.77B
Bonne46.01B
Outin Futures42.39B
Sewha P&C INC.37.65B
Csa Cosmic27.93B
Nord Mason21.26B
Revenue Rankings